Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is an informal nickname for retatrutide, a powerful new tripleagonist weightloss medication that is still in clinical trials and not yet FDAapproved. This article explains what GLP3 really refers to, how retatrutide works, what the research shows so far
The surge in demand for semaglutide has led many patients to explore compounded alternatives
Choosing smaller portions, grilled options, and limiting high-fat items improves both outcomes and tolerability
What is FDA-approved in the GLP-1 space today FDA-approved GLP-1 and incretin-pathway medications include drugs such as exenatide, liraglutide, dulaglutide, semaglutide, and tirzepatide, depending on indication and brand
Cost of weight loss drugs Monthly rate for weight loss drugs
Most users report positive mood effects from Retatrutide, likely related to improved body composition satisfaction
![In an earlier analysis of the SURMOUNT-1 trial, tirzepatide (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3585945231426876830)
![Tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 NEJM Study Explained]](https://belite.com/wp-content/uploads/2025/06/July-2025-Blog-Post-Belite.png)
